ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis

Detalles Bibliográficos
Autores principales: Alicandro, G., Dacco’, V., Cariani, L., Contarini, M., Rosazza, C., Sciarrabba, C.S., Ferraro, F., Orena, B.S., Colombo, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. 2022
Materias:
E-Poster Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184774/
http://dx.doi.org/10.1016/S1569-1993(22)00314-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184774/
http://dx.doi.org/10.1016/S1569-1993(22)00314-9

Ejemplares similares